We’re committed to developing a wide range of guidance that supports good practice in oncology and service delivery – and reflects the changing healthcare landscape. We’re working on a range of new resources for 2023. Please see a list below of future guidance and an estimated timeframe for publication. View all current clinical oncology publications.
Updates of existing guidance
A review of the use of radiotherapy in the UK for the treatment of benign clinical conditions and benign tumours (third edition)
- View current edition
- Due to be published early Spring 2023
Radiotherapy dose fractionation (fourth edition)
- View current edition
- Due to be published Autumn 2023
Timely delivery of radical radiotherapy: guidelines for the management of unscheduled treatment interruptions (fifth edition)
- View current edition
- Due to be published late 2023
New resources in development
Consensus statements for gynaecological cancer
- A steering group of gynaecological cancer experts has been recruited to lead on the development of consensus statements aimed at reducing variation in gynaecological cancer practice.
- Final statements expected late 2023/early 2024
Consensus statements for bladder cancer
- All UK bladder radiotherapy leads were invited to a bladder consensus meeting, held in Summer 2022, to discuss and vote on statements aimed at improving standards of bladder cancer care.
- The final statements are expected to be published by Spring 2023
Recommendations for radiotherapy treatment contouring for vulva cancer
- This guidance aims to standardise vulva cancer contouring in the UK.
- Due to be published Spring 2023
Principles of re-irradiation
- There is an increasing utilisation of a second course of radiotherapy to treat recurrent or relapsed disease. The RCR has identified this as an emerging important area of clinical activity and research which would benefit from a top-level guidance document to guide practitioners.
- Due to be published by Autumn 2023
Combined chemo/radiotherapy consent forms
- The RCR is developing its first national site-specific combined chemo-radiotherapy consent forms. The plan is to begin with forms for bladder, head and neck, rectal and anal cancer.
- View the latest updates on all the RCR’s radiotherapy consent forms
Guidance on best practice for multidisciplinary team meetings and peer review
- This is a joint Faculty document